Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vitro preparation of prefibrillar intermediates of amyloid-beta and alpha-synuclein.

Methods in molecular biology (Clifton, N.J.) - 1 Jan 2005

Lashuel Hilal A, Grillo-Bosch Dolors

Abstract excerpt

Elucidating the structural properties of early intermediates (protofibrils) on the fibril formation pathway of Abeta and alpha-synuclein, the structural relationship among the different intermediates and their relationship to the structure of the amyloid fibrils is critical for understanding the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha-Synuclein
Share to Alzheimer Disease
Share to Amyloid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Amyloid beta-Peptides

Share to Mutation

Share to Nerve Tissue Proteins

Share to Synucleins

Source

Identifiers

PMID: 15980593
DOI: 10.1385/1-59259-874-9:019

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-15980593-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In vitro preparation of prefibrillar intermediates of amyloid-beta and alpha-synuclein.PMID 15980593Read ↗

An improved method for generating consistent soluble amyloid-beta oligomer preparations for in vitro neurotoxicity studiesSemantic proximity Read ↗

The contribution of biophysical and structural studies of protein self-assembly to the design of therapeutic strategies for amyloid diseasesSemantic proximity Read ↗

Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis.Semantic proximity Read ↗

Amyloid β-protein oligomers and Alzheimer’s diseaseSemantic proximity Read ↗

Biophysical approaches to characterising protein-protein interactions and intermediate species in protein aggregationSemantic proximity Read ↗

Mechanistic Models of Protein Aggregation Across Length-Scales and Time-Scales: From the Test Tube to Neurodegenerative DiseaseSemantic proximity Read ↗

Biochemical Properties of Pathology-Related Tau Species in Tauopathy Brains: An Extraction Protocol for Tau Oligomers and Aggregates.Semantic proximity Read ↗

The status of the terminal regions of α-synuclein in different forms of aggregates during fibrillization.Semantic proximity Read ↗

Structural mechanisms of oligomer and amyloid fibril formation by the prion protein.Semantic proximity Read ↗

Protofibrils, the unifying toxic molecule of neurodegenerative disorders?Semantic proximity Read ↗

Alzheimer’s Disease Brain Organoids as a Source of Disease-Relevant Amyloid-Beta OligomersSemantic proximity Read ↗

Synthesis, aggregation, neurotoxicity, and secondary structure of various Aβ1–42 mutants of familial Alzheimer's disease at positions 21–23Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.